Skip to content
Disclosery

GILEAD SCIENCES, INC.

Follow

13F filer, CIK 882095, FOSTER CITY, CA

GILEAD SCIENCES, INC. reported $1,935,507,854 across 6 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001123292-26-000164

Period
2025-12-31
Reported value
$1.94B
Holdings
6
Top 10 weight
100%
New
0
Sold out
3

Part of the filer group GILEAD SCIENCES, INC.

How groups are built

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MERUS N Vexited-452,527-$42.6M
TNGXexited-4,854,443-$40.8M
CYPHexited-5,319,148-$2.41M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001123292-26-000164, largest first. % of portfolio is the value over $1,935,507,854, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 30,061,124 shares; 2025Q1: 31,424,760 shares; 2025Q2: 31,424,760 shares; 2025Q3: 31,424,760 shares; 2025Q4: 31,424,760 shares 31,424,760$749M38.69%0Timeline
LKFTLAKEFRONT BIOTHERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 16,707,477 shares; 2025Q1: 16,707,477 shares; 2025Q2: 16,707,477 shares; 2025Q3: 16,707,477 shares; 2025Q4: 16,707,477 shares 16,707,477$551M28.45%0Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 6,720,803 shares; 2025Q1: 6,720,803 shares; 2025Q2: 6,720,803 shares; 2025Q3: 6,720,803 shares; 2025Q4: 6,720,803 shares 6,720,803$438M22.64%0Timeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 2,209,471 shares; 2025Q1: 2,209,471 shares; 2025Q2: 2,209,471 shares; 2025Q3: 4,505,391 shares; 2025Q4: 4,505,391 shares 4,505,391$153M7.92%0Timeline
KYTXKYVERNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 4,126,119 shares; 2025Q1: 4,126,119 shares; 2025Q2: 4,126,119 shares; 2025Q3: 4,126,119 shares; 2025Q4: 4,126,119 shares 4,126,119$38.8M2%0Timeline
XLOXilio Therapeutics Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 9,105,451 shares; 2025Q1: 9,105,451 shares; 2025Q2: 9,105,451 shares; 2025Q3: 9,105,451 shares; 2025Q4: 9,105,451 shares 9,105,451$5.83M0.3%0Timeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MERUS N VMERUS N V452,527$42.6Mshares
TNGXTANGO THERAPEUTICS INC4,854,443$40.8Mshares
CYPHCYPHERPUNK TECHNOLOGIES INC5,319,148$2.41Mshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001123292-26-000164 base2026-02-12acceptance time not in the bulk data set